The federal government’s COVID-19 public health emergency (PHE) declaration will end on May 11, 2023. The drug poisoning PHE, first…
This session will focus on the emerging role of digital therapeutics (DTx) in the treatment of substance use disorders (SUDs),…
Recently, the Federal Trade Commission (FTC) took action against Benefytt Technologies for selling “sham” health care plans. According to the…
Aimed Alliance’s staff attorney, Ashira Vantrees, spoke with the Patient Empowerment Network for their May 2022 Activity Guide on “How…
In May 2022, the Digital Therapeutics Alliance released a report titled DTx Value Assessment & Integration Guide. This new report…
On May 11, 2022, Aimed Alliance’s staff attorney, Ashira Vantrees, participated as a panelist on Healthy Women’s Virtual Policy Discussion…
On March 29, 2022, Aimed Alliance hosted a webinar through HR.com titled “Covering Prescription Digital Therapeutics: A Win-Win for Employers…
Aimed Alliance Teams with HR.com, Center for U.S. Policy, Others To Inform Corporate Executives, Members of Congress WASHINGTON, March 28, 2022 /PRNewswire/…
On March 25, 2022, Aimed Alliance and 31 other not-for-profit organizations and patient-advocacy groups sent a letter to Senators Shaheen…
WASHINGTON, March 23, 2022 /PRNewswire/ — Today, Aimed Alliance, the Center for U.S. Policy and the International Health Facility Diversion Association commended the…